Analyst Ratings for Lyell Immunopharma (LYEL)
LYEL Rating Summary
LYEL Price Target Summary
- Highest: $49.00 (Baird)
- Lowest: $12.00 (BofA Securities)
- Average: $35.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$35.50 (+144.3%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
Rating Score: 6.4 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/5/2026 | Stifel | Stephen Willey | New Coverage | Buy (N/A) |
36.00 (N/A) |
13.60 (14.53) |
6.84% | Details |
| 7/22/2026 | B.Riley | Yuan Zhi | New Coverage | Buy (N/A) |
44.00 (N/A) |
12.92 (14.53) |
12.46% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
